Cargando…

Extra cost of brain metastases (BM) in patients with non-squamous non-small cell lung cancer (NSCLC): a French national hospital database analysis

PURPOSE: To assess the incremental cost associated with the management of patients with primary non-squamous non-small cell lung cancer (NSCLC) with brain metastases at the time of diagnosis. METHODS: Data were extracted from the French Hospital medical information database (Programme de Médicalisat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Girard, Nicolas, Cozzone, Delphine, de Leotoing, Lucie, Tournier, Charlène, Vainchtock, Alexandre, Tehard, Bertrand, Cortot, Alexis B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135444/ https://www.ncbi.nlm.nih.gov/pubmed/30233822 http://dx.doi.org/10.1136/esmoopen-2018-000414

Ejemplares similares

Hospital burden of pulmonary arterial hypertension in France
por: Bergot, Emmanuel, et al.
Publicado: (2019)

Osimertinib alone as second-line treatment for brain metastases (BM) control may be more limited than for non-BM in advanced NSCLC patients with an acquired EGFR T790M mutation
por: Li, Changhui, et al.
Publicado: (2021)

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19
por: Cui, W., et al.
Publicado: (2021)

Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment)
por: Fernandes, Jérôme, et al.
Publicado: (2017)

Paclitaxel–bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study
por: Bilger, Geoffroy, et al.
Publicado: (2022)

Costs and mortality associated with HIV: a machine learning analysis of the French national health insurance database
por: Prodel, Martin, et al.
Publicado: (2021)

Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study
por: Scherpereel, Arnaud, et al.
Publicado: (2018)

Cost-effectiveness of alectinib compared to crizotinib for the treatment of first-line ALK+ advanced non-small-cell lung cancer in France
por: Sivignon, Marine, et al.
Publicado: (2020)

External Validation of the LabBM Score in Patients With Brain Metastases
por: Nieder, Carsten, et al.
Publicado: (2019)

The surgical treatment of idiopathic abnormal uterine bleeding: An analysis of 88 000 patients from the French exhaustive national hospital discharge database from 2009 to 2015
por: de Léotoing, Lucie, et al.
Publicado: (2019)

Cause of death in patients with atrial fibrillation admitted to French hospitals in 2012: a nationwide database study
por: Fauchier, Laurent, et al.
Publicado: (2015)

Pazopanib diminishes non-small cell lung cancer (NSCLC) growth and metastases in vivo
por: Zhao, Honglin, et al.
Publicado: (2015)

Salvage Immunotherapy With Pembrolizumab in Patients Hospitalized for Life-Threatening Complications of NSCLC
por: Roborel de Climens, Ferréol, et al.
Publicado: (2021)

Immunotherapy in NSCLC Patients with Brain Metastases
por: Buriolla, Silvia, et al.
Publicado: (2022)

Interaction of Destruxin A with Three Silkworm Proteins: BmCRT, BmDPP3, and BmPDIA5
por: Yin, Xuyu, et al.
Publicado: (2022)

Determinants of malignant pleural mesothelioma survival and burden of disease in France: a national cohort analysis
por: Chouaid, Christos, et al.
Publicado: (2018)

Response Assessment in Brain Metastases Managed by Stereotactic Radiosurgery: A Reappraisal of the RANO-BM Criteria
por: Douri, Keiss, et al.
Publicado: (2023)

Potential role of oxidative exoenzymes of the extremophilic fungus Pestalotiopsis palmarum BM-04 in biotransformation of extra-heavy crude oil
por: Naranjo-Briceño, Leopoldo, et al.
Publicado: (2013)

Treatment patterns and survival in an exhaustive French cohort of pazopanib-eligible patients with metastatic soft tissue sarcoma (STS)
por: Ray-Coquard, Isabelle, et al.
Publicado: (2017)

Innovative Approach for a Typology of Treatment Sequences in Early Stage HER2 Positive Breast Cancer Patients Treated With Trastuzumab in the French National Hospital Database
por: Tredan, Olivier, et al.
Publicado: (2022)

EGFR-Driven Mutation in Non-Small-Cell Lung Cancer (NSCLC) Influences the Features and Outcome of Brain Metastases
por: Armocida, Daniele, et al.
Publicado: (2023)

Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases
por: Pierret, Thomas, et al.
Publicado: (2022)

Knockdown of BmTCP-1β Delays BmNPV Infection in vitro
por: Wang, Xue-yang, et al.
Publicado: (2019)

Outcome of EGFR-mutated NSCLC patients with MET-driven resistance to EGFR tyrosine kinase inhibitors
por: Baldacci, Simon, et al.
Publicado: (2017)

ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four cases
por: Cappuzzo, F, et al.
Publicado: (2003)

IGDB.NSCLC: integrated genomic database of non-small cell lung cancer
por: Kao, Sen, et al.
Publicado: (2012)

Hospital costs of Balloon Pulmonary Angioplasty (BPA) procedure and management for CTEPH patients: An observational study based on the French national hospital discharge database (PMSI)
por: Cottin, Vincent, et al.
Publicado: (2021)

BmREEPa Is a Novel Gene that Facilitates BmNPV Entry into Silkworm Cells
por: Dong, Xiao-long, et al.
Publicado: (2015)

Intracranial efficacy and safety of furmonertinib 160 mg with or without anti-angiogenic agent in advanced NSCLC patients with BM/LM as salvage therapy
por: Xu, Ziyi, et al.
Publicado: (2023)

Cutaneous metastases as a presenting sign of metastatic NSCLC
por: McSweeney, William T, et al.
Publicado: (2019)

The road of NSCLC stem cells toward bone metastases
por: Bertolini, Giulia, et al.
Publicado: (2022)

Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study
por: Duruisseaux, Michaël, et al.
Publicado: (2017)

Naomi Richman, BM, FRCPsych
por: Graham, Philip
Publicado: (2019)

BM1: Events Guide
Publicado: (2020)

BmTEdb: a collective database of transposable elements in the silkworm genome
por: Xu, Hong-En, et al.
Publicado: (2013)

Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database
por: Scanvion, Quentin, et al.
Publicado: (2020)

BmTudor-sn Is a Binding Protein of Destruxin A in Silkworm Bm12 Cells
por: Wang, Jingjing, et al.
Publicado: (2019)

Identification of Peritrophins and Antiviral Effect of Bm01504 against BmNPV in the Silkworm, Bombyx mori
por: Zha, Xu-Le, et al.
Publicado: (2020)

Activity of crizotinib over choroidal metastases in Non-Small-Cell Lung Cancer (NSCLC)-ALK rearranged: a case report
por: Bearz, Alessandra, et al.
Publicado: (2014)

The Surgical Management of Brain Metastases in Non-Small Cell Lung Cancer (NSCLC): Identification of the Early Laboratory and Clinical Determinants of Survival
por: Schneider, Matthias, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p5hcetl4m47e2nifqtt8tfmnup